» Articles » PMID: 35585925

Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke

Overview
Journal Front Neurosci
Date 2022 May 19
PMID 35585925
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is defined as an infarction in the brain, caused by impaired cerebral blood supply, leading to local brain tissue ischemia, hypoxic necrosis, and corresponding neurological deficits. At present, revascularization strategies in patients with acute ischemic stroke include intravenous thrombolysis and mechanical endovascular treatment. However, due to the short treatment time window (<4.5 h) and method restrictions, clinical research is focused on new methods to treat ischemic stroke. Exosomes are nano-sized biovesicles produced in the endosomal compartment of most eukaryotic cells, containing DNA, complex RNA, and protein (30-150 nm). They are released into surrounding extracellular fluid upon fusion between multivesicular bodies and the plasma membrane. Exosomes have the characteristics of low immunogenicity, good innate stability, high transmission efficiency, and the ability to cross the blood-brain barrier, making them potential therapeutic modalities for the treatment of ischemic stroke. The seed sequence of miRNA secreted by exosomes is base-paired with complementary mRNA to improve the microenvironment of ischemic tissue, thereby regulating downstream signal transduction activities. With exosome research still in the theoretical and experimental stages, this review aims to shed light on the potential of exosomes derived from mesenchymal stem cells in the treatment of ischemic stroke.

Citing Articles

Scalable production of anti-inflammatory exosomes from three-dimensional cultures of canine adipose-derived mesenchymal stem cells: production, stability, bioactivity, and safety assessment.

Thongsit A, Oontawee S, Siriarchavatana P, Rodprasert W, Somparn P, Na Nan D BMC Vet Res. 2025; 21(1):81.

PMID: 39979916 PMC: 11841348. DOI: 10.1186/s12917-025-04517-1.


Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders.

Toader C, Tataru C, Munteanu O, Covache-Busuioc R, Serban M, Ciurea A Int J Mol Sci. 2025; 25(24.

PMID: 39769374 PMC: 11728275. DOI: 10.3390/ijms252413614.


Transplantation of Exosomes Derived From Human Wharton's Jelly Mesenchymal Stromal Cells Enhances Functional Improvement in Stroke Rats.

Chiu Y, Wu K, Yu S, Wu K, Hsieh C, Chou Y Cell Transplant. 2024; 33:9636897241296366.

PMID: 39624898 PMC: 11613244. DOI: 10.1177/09636897241296366.


Challenges in tendon-bone healing: emphasizing inflammatory modulation mechanisms and treatment.

Jiang F, Zhao H, Zhang P, Bi Y, Zhang H, Sun S Front Endocrinol (Lausanne). 2024; 15:1485876.

PMID: 39568806 PMC: 11576169. DOI: 10.3389/fendo.2024.1485876.


Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models.

Xu K, Zhao X, He Y, Guo H, Zhang Y Front Pharmacol. 2024; 15:1481617.

PMID: 39508049 PMC: 11537945. DOI: 10.3389/fphar.2024.1481617.


References
1.
Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J . Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020; 17(1):46. PMC: 6998092. DOI: 10.1186/s12974-020-1725-8. View

2.
Salikhova D, Bukharova T, Cherkashova E, Namestnikova D, Leonov G, Nikitina M . Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats. Int J Mol Sci. 2021; 22(9). PMC: 8125106. DOI: 10.3390/ijms22094694. View

3.
Chen W, Huang W, Yang Y, Li K . Methylglyoxal Scavengers Attenuate Angiogenesis Dysfunction Induced by Methylglyoxal and Oxygen-Glucose Deprivation. Oxid Med Cell Longev. 2022; 2022:8854457. PMC: 8754597. DOI: 10.1155/2022/8854457. View

4.
Lou Y, Guo F, Liu F, Gao F, Zhang P, Niu X . miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem. 2012; 370(1-2):45-51. DOI: 10.1007/s11010-012-1396-6. View

5.
Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View